Clinical Trials Browser

Phase 2 × Recruiting × Mesothelioma × Clear all

Mesothelioma

NCT06503146 2025-11-12

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT06057935 2025-07-22

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Phase 2 Recruiting

64 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT03935893 2025-07-10

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Phase 2 Recruiting

240 enrolled

DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT04515836 2025-05-06

Olaparib in Patients With HRD Malignant Mesothelioma

Phase 2 Recruiting

56 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma

Clinical Trials

MAGIC-AKI

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Olaparib in Patients With HRD Malignant Mesothelioma